Displaying results 13 - 24 of 733
Liver Tumours
Spatial transcriptomic profiling reveals distinct stromal and clonal dynamics in liver cancer

Spatial transcriptomic profiling reveals distinct stromal and clonal dynamics in liver cancer

ePosters
View
Liver Tumours
Targeting UBE2I-mediated protein hyper-SUMOylation halts cholangiocarcinoma progression and rewires the tumor-stroma crosstalk

Targeting UBE2I-mediated protein hyper-SUMOylation halts cholangiocarcinoma progression and rewires the tumor-stroma crosstalk

ePosters
View
Liver Tumours
The hepatocyte nuclear factor 1 homeobox A (HNF1A) gene polymorphism and AFP serum levels in Egyptian HCC patients

The hepatocyte nuclear factor 1 homeobox A (HNF1A) gene polymorphism and AFP serum levels in Egyptian HCC patients

ePosters
View
Liver Tumours
The usefulness of novel cholangiocarcinoma cell lines with enhanced resistance to cisplatin or 5-fluorouracil to study mechanisms of chemoresistance

The usefulness of novel cholangiocarcinoma cell lines with enhanced resistance to cisplatin or 5-fluorouracil to study mechani...

ePosters
View
Liver Tumours
Recapitulating the liver tumour endothelium in vitro: a tool for novel drug delivery studies

Recapitulating the liver tumour endothelium in vitro: a tool for novel drug delivery studies

ePosters
View
Liver Tumours
Role of post-translational modification (PTM) in liver cancer: HuR SUMOylation

Role of post-translational modification (PTM) in liver cancer: HuR SUMOylation

ePosters
View
Liver Tumours
Role of the splicing factor poly(rC)-binding protein 2 in cholangiocarcinoma malignancy and chemoresistance

Role of the splicing factor poly(rC)-binding protein 2 in cholangiocarcinoma malignancy and chemoresistance

ePosters
View
Liver Tumours
Scavenger receptor MARCO is associated with an immunosuppressive microenvironment and tumor progression in intrahepatic cholangiocarcinoma

Scavenger receptor MARCO is associated with an immunosuppressive microenvironment and tumor progression in intrahepatic cholan...

ePosters
View
Liver Tumours
Selective targeting of class I histone deacetylases with new derivatives of ursodeoxycholic acid as a novel treatment strategy for bile duct cancer

Selective targeting of class I histone deacetylases with new derivatives of ursodeoxycholic acid as a novel treatment strategy...

ePosters
View
Liver Tumours
Pattern of expression, immune contexture and clinical correlates of tertiary lymphoid structures (TLS) in biliary tract cancer (BTC)

Pattern of expression, immune contexture and clinical correlates of tertiary lymphoid structures (TLS) in biliary tract cancer...

ePosters
View
Liver Tumours
Pattern of progression and post-progression survival in intermediate stage hepatocellular carcinoma. An analysis of the TACE 2 trial

Pattern of progression and post-progression survival in intermediate stage hepatocellular carcinoma. An analysis of the TACE 2...

ePosters
View
Liver Tumours
Pivotal role of Fibroblast growth factor 21 in protecting against liver injury and decelerating hepatocarcinogenesis by regulating oxidative stress response in non-steatotic liver disease

Pivotal role of Fibroblast growth factor 21 in protecting against liver injury and decelerating hepatocarcinogenesis by regula...

ePosters
View